V
BHC icon

Veritable’s Bausch Health BHC Stock Holding History

Veritable’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,255
Closed -$581K – 739
2015
Q3 		$581K Buy
3,255
+1,114
+52% +$260K 0.02% 409
2015
Q2 		$476K Sell
2,141
-22
-1% -$4.88K 0.01% 472
2015
Q1 		$430K Sell
2,163
-8
-0.4% -$1.42K 0.01% 642
2014
Q4 		$311K Sell
2,171
-430
-17% -$57.8K 0.01% 733
2014
Q3 		$341K Buy
2,601
+20
+0.8% +$2.38K 0.01% 733
2014
Q2 		$326K Buy
2,581
+2
+0.1% +$255 0.01% 736
2014
Q1 		$340K Buy
2,579
+87
+3% +$11.9K 0.01% 691
2013
Q4 		$293K Buy
2,492
+37
+2% +$4.05K 0.01% 721
2013
Q3 		$256K Buy
2,455
+45
+2% +$4.38K 0.01% 778
2013
Q2 		$207K Buy
+2,410
New +$190K 0.01% 855

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Veritable's BHC Position: Q4 2015 in Review

Veritable sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 3,255 shares — an estimated $581K sold.

Veritable first reported a position in BHC in Q2 2013 and held it in 10 quarters. The position peaked at $581K in Q3 2015. 451 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

  • Veritable reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
  • Veritable sold 3,255 Bausch Health shares in Q4 2015, an estimated $581K.
  • Veritable first reported a position in Bausch Health in Q2 2013 and held it in 10 quarters.
  • Veritable's Bausch Health position peaked at $581K in Q3 2015.
  • 451 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on Veritable's 13F filing for Q4 2015, filed 10 Feb 2016.